Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong financial performance with a 19% increase in EBITDA, improved occupancy, and positive RevPAR growth. Despite missing free cash flow guidance, the company shows progress in leverage reduction and resident satisfaction. The Q&A highlights strategic initiatives like HealthPlus expansion and a centralized pricing strategy, which bolster growth prospects. While some guidance details were vague, overall sentiment is positive with raised EBITDA guidance, occupancy gains, and strategic focus on operational efficiency. Given the market cap, a positive stock price reaction of 2% to 8% is expected over the next two weeks.
RevPAR growth 5.7% for 2025, at the top end of initial guidance. This was driven by positive occupancy and pricing trends.
Adjusted EBITDA $458 million for 2025, a 19% year-over-year increase. This exceeded initial expectations and marked the fourth consecutive year of double-digit growth. Growth was attributed to improved occupancy and operational efficiencies.
Occupancy 82.5% weighted average for Q4 2025, a 310 basis point improvement year-over-year. Growth was supported by market demand, internal focus on occupancy, and SWAT team initiatives.
Adjusted Free Cash Flow $23 million for 2025, marking the first positive year since 2020. Fell short of the $30-$50 million guidance due to working capital timing and refinancing-related interest prepayments.
Nondevelopment CapEx $170.7 million for 2025, focused on community reinvestments to improve NOI and aesthetics.
Leverage 8.9x adjusted EBITDA at the end of 2025, improved from 9.9x in 2024. Improvement was driven by adjusted EBITDA growth.
Resident Fees $3 billion for 2025, a 2.4% year-over-year increase. Growth was driven by a 5.7% increase in RevPAR, offset by a 3.2% decline in available units due to portfolio optimization.
Net Promoter Score (NPS) Increased by 19 points since 2022, reflecting improved resident satisfaction.
Brookdale HealthPlus Expansion: Expanded into 58 additional communities across 8 states, including 3 new states, bringing the total to over 180 communities served.
Demographic Trends: The population of 80+ year-old Americans is expected to grow at a 4%+ compounded annual rate for the next decade, while senior housing supply growth is at a historical low of 0.6%.
Occupancy Growth: Achieved a weighted average occupancy of 82.5% in Q4 2025, the highest since Q1 2020, with a 310 basis point improvement year-over-year.
Adjusted EBITDA Growth: Grew adjusted EBITDA by 19% to $458 million in 2025, marking the fourth consecutive year of double-digit growth.
Portfolio Optimization: Exited 58 leased communities and sold 12 owned communities in 2025, with plans to sell 29 more owned communities in 2026, generating approximately $200 million in proceeds.
Operational Restructuring: Introduced a new regional operating structure with 6 leadership teams and created a Senior VP of Strategic Operations role to centralize pricing, labor management, and capital investment decisions.
Leverage Reduction: Reduced adjusted annualized leverage to 8.9x in 2025, with a goal to bring it below 6x by 2028.
Occupancy Challenges: Despite improvements, 80 communities remain below the 70% occupancy threshold, with 14 expected to be sold and 21 requiring intervention from SWAT teams. This indicates ongoing challenges in achieving optimal occupancy levels.
Portfolio Optimization Risks: The company plans to sell 29 owned communities by mid-2026, which could disrupt operations and revenue streams during the transition period.
Leverage and Debt Management: Brookdale's adjusted annualized leverage remains high at 8.9x adjusted EBITDA, posing financial risks despite improvements. The company aims to reduce leverage to under 6x by 2028, but this is contingent on sustained EBITDA growth.
Labor Costs and Turnover: Labor remains the largest cost item at 65% of facility operating expenses. While turnover has improved, it still poses a risk to operational stability and cost management.
Economic and Market Conditions: The company is reliant on demographic trends and limited senior housing supply for growth. Any adverse changes in these conditions could impact occupancy and revenue.
Regulatory and Compliance Risks: Brookdale operates in a highly regulated industry, and any changes in regulations or compliance requirements could increase costs or limit operational flexibility.
Capital Investment Risks: The company plans to invest $175 million to $195 million in non-development capital projects in 2026. Mismanagement or delays in these investments could impact community-level NOI and occupancy growth.
Revenue Per Available Room (RevPAR) Growth: Brookdale is projecting RevPAR growth of 8% to 9% for 2026, driven by higher in-place rate increases, strong move-in demand, and the accretive impact of disposition communities.
Adjusted EBITDA: Brookdale expects adjusted EBITDA to grow to a range of $502 million to $516 million in 2026, representing mid-teen annual growth from the 2025 baseline of $445 million. The company also anticipates maintaining mid-teens adjusted EBITDA growth through 2028.
Occupancy Rates: Occupancy is expected to continue improving, supported by strong move-in demand and demographic trends. The company anticipates further income flow-through as occupancy increases beyond the 80% level, which is pivotal for leveraging fixed costs.
Capital Expenditures: Brookdale plans to invest $175 million to $195 million in nondevelopment capital projects in 2026, focusing on community improvements that enhance occupancy and NOI.
Portfolio Optimization: Brookdale anticipates completing the sale of 29 owned communities by mid-2026, generating approximately $200 million in proceeds. This will streamline the portfolio to 517 owned and leased communities, improving occupancy, RevPAR, and adjusted EBITDA.
Leverage Reduction: Brookdale aims to reduce leverage to under 6x by the end of 2028, primarily through adjusted EBITDA expansion. The adjusted annualized leverage at the end of 2025 was 8.9x, down from 9.9x in the prior year.
Market Trends and Demographics: The population of Americans aged 80 and above is expected to grow at a 4% compounded annual rate over the next decade, while senior housing supply growth remains historically low at 0.6%. This imbalance is expected to drive increasing occupancy across the senior living industry.
The selected topic was not discussed during the call.
The earnings call reveals strong financial performance with a 19% increase in EBITDA, improved occupancy, and positive RevPAR growth. Despite missing free cash flow guidance, the company shows progress in leverage reduction and resident satisfaction. The Q&A highlights strategic initiatives like HealthPlus expansion and a centralized pricing strategy, which bolster growth prospects. While some guidance details were vague, overall sentiment is positive with raised EBITDA guidance, occupancy gains, and strategic focus on operational efficiency. Given the market cap, a positive stock price reaction of 2% to 8% is expected over the next two weeks.
The earnings call summary indicates strong financial performance, with raised guidance for RevPAR and EBITDA, suggesting optimism. The Q&A section highlights strategic initiatives and opportunities, such as the 'silver tsunami' trend and pricing strategies, which are positively viewed by analysts. However, some uncertainty remains regarding occupancy gains and EBITDA margin growth specifics. The raised guidance and strategic focus on market opportunities, combined with a positive market sentiment, suggest a positive stock price movement in the next two weeks, especially considering the company's small-cap status.
The earnings call shows strong financial performance with RevPAR and occupancy growth, improved operating income, and increased liquidity. Positive sentiment is reinforced by strategic initiatives targeting occupancy and pricing, and an optimistic outlook on moving communities out of low occupancy bands. Despite some concerns about discounting and unchanged cash flow guidance, the raised EBITDA guidance and operational improvements suggest a positive stock price movement over the next two weeks.
The earnings call reveals strong financial performance with a 27% increase in RevPAR and adjusted EBITDA, and improved occupancy. Despite no shareholder return plans, strategic initiatives and pricing power are promising. The Q&A indicates confidence in dynamic pricing and operational improvements. While macroeconomic uncertainties exist, the raised EBITDA guidance and sustainable changes by SWAT teams are positive indicators. Given the small-cap nature, the stock is likely to react positively, potentially in the 2% to 8% range.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.